| Systems-Structure-Based Drug Design | Oct 14, 2024 | Drug DesignDrug Discovery | —Unverified | 0 |
| Boltzmann-Aligned Inverse Folding Model as a Predictor of Mutational Effects on Protein-Protein Interactions | Oct 12, 2024 | Drug DesignInductive Bias | —Unverified | 0 |
| SynthFormer: Equivariant Pharmacophore-based Generation of Synthesizable Molecules for Ligand-Based Drug Design | Oct 3, 2024 | Drug DesignDrug Discovery | —Unverified | 0 |
| Enhancing Solution Efficiency in Reinforcement Learning: Leveraging Sub-GFlowNet and Entropy Integration | Oct 1, 2024 | Computational EfficiencyDiversity | —Unverified | 0 |
| Binding Affinity Prediction: From Conventional to Machine Learning-Based Approaches | Sep 30, 2024 | Drug DesignDrug Discovery | —Unverified | 0 |
| FlexSBDD: Structure-Based Drug Design with Flexible Protein Modeling | Sep 29, 2024 | Data AugmentationDrug Design | —Unverified | 0 |
| PepINVENT: Generative peptide design beyond the natural amino acids | Sep 21, 2024 | Drug Design | —Unverified | 0 |
| Self-Organizing Maps of Unbiased Ligand-Target Binding Pathways and Kinetics | Sep 19, 2024 | Drug DesignDrug Discovery | —Unverified | 0 |
| GFlowNet Pretraining with Inexpensive Rewards | Sep 15, 2024 | Drug DesignUnsupervised Pre-training | —Unverified | 0 |
| Quantum-inspired Reinforcement Learning for Synthesizable Drug Design | Sep 13, 2024 | Drug DesignDrug Discovery | —Unverified | 0 |
